Sophie PIPERNO-NEUMANN
Institut Curie · Institut Curie Paris
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sophie PIPERNO-NEUMANN as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:46 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04424719 · Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)Institut Curie · recruiting · Uveal Melanoma · principal investigator
- N/ANCT04055220 · Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone SarcomasCentre Leon Berard · recruiting · Bone Sarcoma, Osteosarcoma, Ewing Sarcoma · principal investigator
- Ph3NCT02843386 · Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal MelanomaInstitut Curie · completed · Uveal Melanoma · principal investigator
- N/ANCT01334008 · Study of Circulating Tumoral DNA in Metastatic Choroidal MelanomaInstitut Curie · completed · Choroidal Melanoma, Diffuse · principal investigator
- Ph2NCT01217398 · Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the EyeInstitut Curie · unknown · Intraocular Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in ewing sarcoma, ranked by citations from NIH iCite, fetched 2026-11-12 12:46 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.Lancet Oncol · 2020276 citationsRCR 13.1
- Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study.Lancet Oncol · 2019273 citationsRCR 10.7